Tag Archives: chemical

Makers of new drugs exempt from price control: Govt.

The Indian Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals) has notified an order amending the Drugs (Prices Control) Order 2013. Effective January 3, 2019, manufacturers of new drugs patented in India are exempt from price control for a period … Continue reading

Posted in Consumer Law, Drugs Law, General Law, Intellectual Property Law, International Law, patent, patent law, TRIPS | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Glenmark restrained from producing anti-diabetic drug: DHC

The Delhi High Court restrained Glenmark Pharmaceuticals from producing and marketing a generic version of Merck’s drug ‘Januvia’ used for treating diabetes. Merck sued Glenmark for infringement of its Indian patent for ‘Januvia’ and ‘Janumet’. Glenmark was selling the generic version … Continue reading

Posted in Intellectual Property Law, International Law, patent, trademark | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Cipla not infringing Pfizer patent for drug Tarceva: DHC

In a big relief to pharmaceutical company Cipla Ltd. (“Cipla”), the Delhi High Court ruled that Cipla did not infringe OSI/Pfizer (“Pfizer”) Indian patent for their drug ‘Erlotinib’ (trade name ‘Tarceva’) by manufacture, marketing and sale of their drug ‘Erlocip’, … Continue reading

Posted in Intellectual Property Law | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment